349 related articles for article (PubMed ID: 36677670)
21. Pharmaceutical cocrystals: a rising star in drug delivery applications.
Panzade P; Wagh A; Harale P; Bhilwade S
J Drug Target; 2024 Dec; 32(2):115-127. PubMed ID: 38164658
[TBL] [Abstract][Full Text] [Related]
22. Pharmaceutical cocrystals: a novel approach for oral bioavailability enhancement of drugs.
Chadha R; Saini A; Arora P; Bhandari S
Crit Rev Ther Drug Carrier Syst; 2012; 29(3):183-218. PubMed ID: 22577957
[TBL] [Abstract][Full Text] [Related]
23. Experimental cocrystal screening and solution based scale-up cocrystallization methods.
Malamatari M; Ross SA; Douroumis D; Velaga SP
Adv Drug Deliv Rev; 2017 Aug; 117():162-177. PubMed ID: 28811184
[TBL] [Abstract][Full Text] [Related]
24. Characterization and Quality Control of Pharmaceutical Cocrystals.
Izutsu KI; Koide T; Takata N; Ikeda Y; Ono M; Inoue M; Fukami T; Yonemochi E
Chem Pharm Bull (Tokyo); 2016 Oct; 64(10):1421-1430. PubMed ID: 27319284
[TBL] [Abstract][Full Text] [Related]
25. Cocrystals of tuberculosis antibiotics: Challenges and missed opportunities.
Salem A; Khanfar E; Nagy S; Széchenyi A
Int J Pharm; 2022 Jul; 623():121924. PubMed ID: 35738333
[TBL] [Abstract][Full Text] [Related]
26. Engineering a Remedy to Modulate and Optimize Biopharmaceutical Properties of Rebamipide by Synthesizing New Cocrystal: In Silico and Experimental Studies.
Jindal A; Singh R; Tomar S; Dureja J; Karan M; Chadha R
Pharm Res; 2021 Dec; 38(12):2129-2145. PubMed ID: 34904202
[TBL] [Abstract][Full Text] [Related]
27. Engineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous Medium.
Sathisaran I; Dalvi SV
Pharmaceutics; 2018 Jul; 10(3):. PubMed ID: 30065221
[TBL] [Abstract][Full Text] [Related]
28. Application of Cocrystallization Approach in Drug Development: Recent Patents Review.
Shah K; Parmar VK
Recent Pat Nanotechnol; 2018; 12(2):143-154. PubMed ID: 29473529
[TBL] [Abstract][Full Text] [Related]
29. Research Progress of Plant Active Ingredients in Pharmaceutical Cocrystal.
Wang Z; Shang H; Gao L; Qiao N
Curr Drug Deliv; 2023; 20(10):1405-1424. PubMed ID: 35993478
[TBL] [Abstract][Full Text] [Related]
30. Cocrystallization for successful drug delivery.
Sun CC
Expert Opin Drug Deliv; 2013 Feb; 10(2):201-13. PubMed ID: 23256822
[TBL] [Abstract][Full Text] [Related]
31. Pharmaceutical cocrystals: along the path to improved medicines.
Duggirala NK; Perry ML; Almarsson Ö; Zaworotko MJ
Chem Commun (Camb); 2016 Jan; 52(4):640-55. PubMed ID: 26565650
[TBL] [Abstract][Full Text] [Related]
32. Nano Cocrystals: Crystal Engineering from a Nanotechnological Perspective.
Kumar A; Nanda A
Curr Pharm Des; 2021; 27(21):2445-2453. PubMed ID: 33183187
[TBL] [Abstract][Full Text] [Related]
33. A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.
Hong C; Xie Y; Yao Y; Li G; Yuan X; Shen H
Pharm Res; 2015 Jan; 32(1):47-60. PubMed ID: 24939640
[TBL] [Abstract][Full Text] [Related]
34. Fabrication of Carbamazepine Cocrystals: Characterization,
Wasim M; Mannan A; Asad MHHB; Amirzada MI; Shafique M; Hussain I
Biomed Res Int; 2021; 2021():6685806. PubMed ID: 33816628
[TBL] [Abstract][Full Text] [Related]
35. Pharmaceutical cocrystals and poorly soluble drugs.
Thakuria R; Delori A; Jones W; Lipert MP; Roy L; Rodríguez-Hornedo N
Int J Pharm; 2013 Aug; 453(1):101-25. PubMed ID: 23207015
[TBL] [Abstract][Full Text] [Related]
36. Pharmaceutical cocrystals: the coming wave of new drug substances.
Brittain HG
J Pharm Sci; 2013 Feb; 102(2):311-7. PubMed ID: 23192888
[TBL] [Abstract][Full Text] [Related]
37. Cocrystals, Salts, and Salt-Solvates of olanzapine; selection of coformers and improved solubility.
Gong W; Mondal PK; Ahmadi S; Wu Y; Rohani S
Int J Pharm; 2021 Oct; 608():121063. PubMed ID: 34481007
[TBL] [Abstract][Full Text] [Related]
38. Recent Advances in Pharmaceutical Cocrystals: From Bench to Market.
Kumar Bandaru R; Rout SR; Kenguva G; Gorain B; Alhakamy NA; Kesharwani P; Dandela R
Front Pharmacol; 2021; 12():780582. PubMed ID: 34858194
[TBL] [Abstract][Full Text] [Related]
39. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
[TBL] [Abstract][Full Text] [Related]
40. Pharmaceutical cocrystals: an overview.
Qiao N; Li M; Schlindwein W; Malek N; Davies A; Trappitt G
Int J Pharm; 2011 Oct; 419(1-2):1-11. PubMed ID: 21827842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
